Sharma East India Hosp and Medical Research Ltd
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services[1]
- Market Cap ₹ 17.7 Cr.
- Current Price ₹ 54.1
- High / Low ₹ 121 / 22.5
- Stock P/E 20.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE -18.6 %
- ROE -40.0 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 66.3 to 50.8 days.
Cons
- Company has a low return on equity of -9.42% over last 3 years.
- Earnings include an other income of Rs.5.35 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11.81 | 12.50 | 16.36 | 17.21 | 17.14 | 16.00 | 14.73 | 16.17 | 8.13 | 17.04 | 20.73 | 18.52 | 23.39 | |
10.55 | 11.31 | 15.11 | 16.33 | 15.51 | 14.54 | 14.09 | 14.24 | 8.79 | 14.79 | 17.43 | 20.40 | 24.85 | |
Operating Profit | 1.26 | 1.19 | 1.25 | 0.88 | 1.63 | 1.46 | 0.64 | 1.93 | -0.66 | 2.25 | 3.30 | -1.88 | -1.46 |
OPM % | 10.67% | 9.52% | 7.64% | 5.11% | 9.51% | 9.12% | 4.34% | 11.94% | -8.12% | 13.20% | 15.92% | -10.15% | -6.24% |
1.05 | 1.04 | 0.55 | 0.22 | 0.26 | 0.07 | 1.11 | 0.03 | 2.83 | 0.06 | 0.06 | 5.31 | 5.35 | |
Interest | 0.91 | 0.59 | 0.76 | 0.48 | 1.08 | 0.73 | 0.88 | 1.15 | 0.69 | 0.70 | 1.18 | 0.95 | 0.87 |
Depreciation | 0.60 | 0.60 | 0.61 | 0.59 | 0.70 | 0.62 | 0.52 | 0.43 | 0.65 | 0.78 | 1.39 | 1.48 | 1.60 |
Profit before tax | 0.80 | 1.04 | 0.43 | 0.03 | 0.11 | 0.18 | 0.35 | 0.38 | 0.83 | 0.83 | 0.79 | 1.00 | 1.42 |
Tax % | 32.50% | 30.77% | -30.23% | 33.33% | 27.27% | 27.78% | 22.86% | 18.42% | 24.10% | 18.07% | -5.06% | 34.00% | |
0.55 | 0.72 | 0.57 | 0.03 | 0.08 | 0.13 | 0.27 | 0.31 | 0.64 | 0.68 | 0.83 | 0.66 | 0.86 | |
EPS in Rs | |||||||||||||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 5% |
3 Years: | 32% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | -5% |
5 Years: | -10% |
3 Years: | -9% |
Last Year: | -40% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
Reserves | 1.71 | 2.43 | 2.03 | 2.05 | 3.32 | 3.46 | 3.73 | 4.12 | 4.76 | 5.44 | 6.41 | 7.07 | 7.66 |
8.12 | 7.89 | 5.97 | 6.47 | 7.51 | 5.38 | 10.89 | 7.42 | 5.98 | 4.35 | 8.30 | 5.04 | 6.66 | |
2.42 | 1.90 | 2.36 | 2.68 | 2.65 | 3.28 | 3.35 | 4.16 | 3.98 | 5.11 | 4.84 | 8.89 | 12.74 | |
Total Liabilities | 16.41 | 16.38 | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 31.22 |
7.68 | 7.65 | 6.58 | 6.01 | 6.40 | 6.07 | 4.73 | 4.41 | 5.51 | 6.85 | 9.10 | 7.70 | 8.67 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 | 1.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.79 | 0.79 | 0.31 | 0.31 | 1.79 | 1.79 | 1.80 | 1.89 | 1.89 | 1.89 | 2.05 | 2.05 | 2.05 |
7.94 | 7.94 | 7.63 | 9.04 | 9.45 | 8.41 | 15.25 | 11.82 | 11.48 | 10.32 | 12.56 | 15.41 | 20.50 | |
Total Assets | 16.41 | 16.38 | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 31.22 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2.60 | 1.40 | -0.20 | -0.14 | 0.82 | 3.12 | -1.43 | 1.21 | 1.40 | 2.03 | 1.28 | -1.13 | |
0.77 | -0.57 | -0.02 | -0.01 | -0.77 | -0.25 | 1.65 | -1.50 | 2.79 | -2.11 | -3.63 | 5.17 | |
-3.75 | -0.80 | -0.81 | 0.19 | -0.08 | -2.80 | 4.74 | -4.74 | -2.16 | -1.78 | 2.77 | -4.20 | |
Net Cash Flow | -0.38 | 0.03 | -1.03 | 0.05 | -0.03 | 0.06 | 4.96 | -5.03 | 2.03 | -1.86 | 0.41 | -0.17 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 10.82 | 32.70 | 46.63 | 57.69 | 49.40 | 74.14 | 85.49 | 107.22 | 120.32 | 72.61 | 75.54 | 50.85 |
Inventory Days | 42.12 | 26.55 | 16.83 | 73.23 | 98.98 | 217.45 | 49.38 | 41.71 | 49.34 | |||
Days Payable | 75.81 | 170.33 | 138.49 | 120.54 | 143.83 | 481.49 | 390.76 | 304.84 | 362.82 | |||
Cash Conversion Cycle | -22.88 | -111.08 | -75.04 | 10.37 | 49.40 | 29.29 | 85.49 | 107.22 | -143.72 | -268.77 | -187.59 | -262.63 |
Working Capital Days | 34.00 | -35.04 | 100.40 | 120.25 | 135.86 | 112.69 | 170.98 | 166.13 | 231.66 | 100.67 | 114.80 | -39.61 |
ROCE % | 11.65% | 11.45% | 8.93% | 4.11% | 8.60% | 6.50% | 1.57% | 8.87% | -8.30% | 10.61% | 12.00% | -18.61% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Nov
-
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For Half Year Ended 30.09.2024
14 Nov - Declaration of non-applicability of SEBI regulations.
- Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended 30Th September, 2024 14 Nov
-
Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended September 30, 2024
14 Nov - Board approved unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended 30Th September 2024 And Other Matters.
9 Nov - Board meeting to approve Q2 financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
SEIHMR is provides medical & healthcare services. It runs a NABH accredited multi specialty hospital viz. Jaipur Hospital at Lal Kothi, Tonk Road, Jaipur.